{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T11:49:05Z","timestamp":1792756145160,"version":"4.5.0"},"reference-count":54,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T00:00:00Z","timestamp":1667779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015661","name":"UCB Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["acrjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Arthritis &amp; Rheumatology"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the long\u2010term safety, tolerability, and efficacy of bimekizumab in patients with active ankylosing spondylitis (AS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with active AS who completed the dose\u2010ranging, 48\u2010week BE AGILE randomized controlled trial were eligible to participate in an open\u2010label extension (OLE) study, in which patients received 160 mg of bimekizumab every 4\u2009weeks. We present the safety and efficacy results through 156\u2009weeks. Missing efficacy data were imputed using nonresponder imputation analysis for binary outcomes and multiple imputation for continuous outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      From weeks 0\u2013156, 280 of 303 patients (exposure\u2010adjusted incidence rate 141.0 per 100 patient\u2010years) experienced \u22651 treatment\u2010emergent adverse event; the most frequent adverse events were nasopharyngitis (8.1 per 100 patient\u2010years) and upper respiratory tract infection (5.0 per 100 patient\u2010years). Additionally, 67 of 303 patients (9.8 per 100 patient\u2010years) had mild to moderate localized fungal infections (28 of 303 patients had\n                      <jats:italic>Candida<\/jats:italic>\n                      infections [3.7 per 100 patient\u2010years] and 23 of 303 patients had oral candidiasis [3.0 per 100 patient\u2010years]), 10 patients had serious infections (1.3 per 100 patient\u2010years), and no cases of active tuberculosis were reported. Active inflammatory bowel disease (1.1 per 100 patient\u2010years), anterior uveitis (0.7 per 100 patient\u2010years), and adjudicated major adverse cardiovascular events (0.3 per 100 patient\u2010years) were infrequent. The efficacy of bimekizumab treatment demonstrated at week 48 was sustained in the OLE study. At week 156, nonresponder imputation analysis showed that 53.7% of patients (72.6% of observed cases) met the Assessment of SpondyloArthritis international Society criteria for 40% improvement and 28.0% of patients (37.9% of observed cases) achieved partial remission; Ankylosing Spondylitis Disease Activity Scores were reduced from baseline (mean\u2009\u00b1\u2009SEM 3.9\u2009\u00b1\u20090.1) to week 48 (2.1\u2009\u00b1\u20090.1) and week 156 (1.9\u2009\u00b1\u20090.1) (multiple imputation). Patients showed sustained improvements in pain, fatigue, physical function, and health\u2010related quality of life.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The safety profile of bimekizumab was found to be consistent with previously demonstrated findings, and no new safety signals were identified. The efficacy of bimekizumab in patients with AS was sustained through 3\u2009years of treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/art.42282","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T10:10:08Z","timestamp":1657707008000},"page":"1943-1958","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis:\n                    <scp>Three\u2010Year<\/scp>\n                    Results From a Phase\n                    <scp>IIb<\/scp>\n                    Randomized Controlled Trial and Its\n                    <scp>Open\u2010Label<\/scp>\n                    Extension Study"],"prefix":"10.1002","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9475-9362","authenticated-orcid":false,"given":"Xenofon","family":"Baraliakos","sequence":"first","affiliation":[{"name":"Rheumazentrum Ruhrgebiet Herne, Ruhr\u2010University Bochum  Bochum Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2130-1246","authenticated-orcid":false,"given":"Atul","family":"Deodhar","sequence":"additional","affiliation":[{"name":"Oregon Health &amp; Science University  Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Dougados","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Department of Rheumatology, H\u00f4pital Cochin, Assistance Publique\u2013H\u00f4pitaux de Paris, INSERM U1153, Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris\u2010Cit\u00e9  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6314-5336","authenticated-orcid":false,"given":"Lianne S.","family":"Gensler","sequence":"additional","affiliation":[{"name":"Department of Rheumatology University of California  San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Molto","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Department of Rheumatology, H\u00f4pital Cochin, Assistance Publique\u2013H\u00f4pitaux de Paris, INSERM U1153, Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris\u2010Cit\u00e9  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8899-9087","authenticated-orcid":false,"given":"Sofia","family":"Ramiro","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands, and Department of Rheumatology, Zuyderland Medical Center  Heerlen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J.","family":"Kivitz","sequence":"additional","affiliation":[{"name":"Altoona Center for Clinical Research  Duncansville Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4537-6015","authenticated-orcid":false,"given":"Denis","family":"Poddubnyy","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Infectious Diseases and Rheumatology, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin  Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marga","family":"Oortgiesen","sequence":"additional","affiliation":[{"name":"UCB Pharma  Raleigh North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Vaux","sequence":"additional","affiliation":[{"name":"UCB Pharma  Slough UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Fleurinck","sequence":"additional","affiliation":[{"name":"UCB Pharma  Brussels Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Shepherd\u2010Smith","sequence":"additional","affiliation":[{"name":"UCB Pharma  Slough UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"de la Loge","sequence":"additional","affiliation":[{"name":"UCB Pharma  Brussels Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"de Peyrecave","sequence":"additional","affiliation":[{"name":"UCB Pharma  Brussels Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9sir\u00e9e","family":"van der Heijde","sequence":"additional","affiliation":[{"name":"Department of Rheumatology Leiden University Medical Center  Leiden The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,11,7]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31591-4"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-00552-4"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.091793"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-018-1784-8"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar4054"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.150037"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-018-0795-4"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-019-0294-7"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2019.1605352"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41042"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210770"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2019-001005"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30066-7"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216118"},{"key":"e_1_2_8_16_1","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/annrheumdis-2021-eular.1124","article-title":"POS0912\u2009Long\u2010term treatment with ixekizumab in patients with axial spondyloarthritis: two\u2010year results from COAST\u2010Y","volume":"80","author":"Braun J","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-219406"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/20.19.5332"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20071978"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212127"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000805"},{"key":"e_1_2_8_22_1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/annrheumdis-2019-eular.3527","article-title":"IL\u201017A and IL\u201017F are secreted by enthesis T cells and synergize with TNF to induce CCL20 from entheseal stromal cells","volume":"78","author":"Bridgewood C","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001306"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.03.037"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00126-4"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2102383"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00125-2"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2102388"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)33161-7"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-216980"},{"key":"e_1_2_8_31_1","first-page":"S72","article-title":"Psychometric and scaline properties of a new quality of life instrument specific to ankylosing spondylitis [abstract]","volume":"42","author":"Helliwell PS","year":"1999","journal-title":"Arthritis Rheum"},{"key":"e_1_2_8_32_1","volume-title":"SF\u201036 health survey: manual and interpretation guide","author":"Ware JE","year":"1993"},{"key":"e_1_2_8_33_1","first-page":"1694","article-title":"Defining spinal mobility in ankylosing spondylitis (AS): the Bath AS Metrology Index","volume":"21","author":"Jenkinson TR","year":"1994","journal-title":"J Rheumatol"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.2.127"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.016717"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.094870"},{"key":"e_1_2_8_38_1","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index","volume":"21","author":"Garrett S","year":"1994","journal-title":"J Rheumatol"},{"key":"e_1_2_8_39_1","first-page":"2281","article-title":"A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index","volume":"21","author":"Calin A","year":"1994","journal-title":"J Rheumatol"},{"key":"e_1_2_8_40_1","volume-title":"SF\u201036 health survey: manual and interpretation guide","author":"Ware J.","year":"1993"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05545-y"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2015.144"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500909"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aau4594"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.11.009"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15015"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-02208-w"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-018-0123-5"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11102"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i18.2162"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41923"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214273"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-1882-2"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.06.022"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204948"}],"container-title":["Arthritis &amp; Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.42282","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/art.42282","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.42282","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T20:16:35Z","timestamp":1759954595000},"score":1,"resource":{"primary":{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/10.1002\/art.42282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,7]]},"references-count":54,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10.1002\/art.42282"],"URL":"https:\/\/doi.org\/10.1002\/art.42282","archive":["Portico"],"relation":{},"ISSN":["2326-5191","2326-5205"],"issn-type":[{"value":"2326-5191","type":"print"},{"value":"2326-5205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,7]]},"assertion":[{"value":"2022-01-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}